Investors

Press Releases

Feb 4, 2020 • 7:30 AM EST

Endonovo Therapeutics Reduces Debt

Jan 30, 2020 • 7:00 AM EST

Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers

Jan 27, 2020 • 7:00 AM EST

Endonovo Therapeutics Announces First SofPulse® Sales to a Veterans Medical Center

Jan 14, 2020 • 9:00 AM EST

Endonovo Therapeutics Announces Issuance of Broad Patent Covering Electromagnetic Treatment of Multiple Sclerosis

Jan 7, 2020 • 8:30 AM EST

Endonovo Therapeutics Announces Issuance of U.S. Patent Covering Apparatus and Method for Electromagnetic Treatment of Neurological Injury or Condition Caused by a Stroke

Dec 23, 2019 • 8:30 AM EST

Endonovo Therapeutics Provides SofPulse® To All NFL Teams

Dec 19, 2019 • 6:24 PM EST

Endonovo Therapeutics Announces Effective Date of Previously Announced Reverse Split of Common Stock

Dec 11, 2019 • 1:40 PM EST

Endonovo Therapeutics Announces Reverse Stock Split - UPDATE

Dec 11, 2019 • 12:47 PM EST

Endonovo Therapeutics Announces Reverse Stock Split

Nov 19, 2019 • 4:35 PM EST

Endonovo Therapeutics Reports Third Quarter 2019 Results

<< Previous
1
2
3
4
5
6
7
8
9
10
...16
Next >>

Show All